WO2002058678A2 - Vorrichtungen und verfahren zur hitzepuls-gestützten transdermalen applikation von wirkstoffen - Google Patents
Vorrichtungen und verfahren zur hitzepuls-gestützten transdermalen applikation von wirkstoffen Download PDFInfo
- Publication number
- WO2002058678A2 WO2002058678A2 PCT/EP2002/000286 EP0200286W WO02058678A2 WO 2002058678 A2 WO2002058678 A2 WO 2002058678A2 EP 0200286 W EP0200286 W EP 0200286W WO 02058678 A2 WO02058678 A2 WO 02058678A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- heating element
- pulse
- skin
- control unit
- heat pulses
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 20
- 239000013543 active substance Substances 0.000 title abstract description 56
- 238000010438 heat treatment Methods 0.000 claims abstract description 66
- 238000005485 electric heating Methods 0.000 claims abstract 2
- 239000004480 active ingredient Substances 0.000 claims description 30
- 229910052751 metal Inorganic materials 0.000 claims description 22
- 239000002184 metal Substances 0.000 claims description 22
- 230000001225 therapeutic effect Effects 0.000 claims description 11
- 241001465754 Metazoa Species 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 150000002739 metals Chemical class 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 230000000699 topical effect Effects 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- -1 nickel metal hydride Chemical class 0.000 claims description 5
- 239000011505 plaster Substances 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 4
- 239000000956 alloy Substances 0.000 claims description 4
- 229910045601 alloy Inorganic materials 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 239000003990 capacitor Substances 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- 229910052718 tin Inorganic materials 0.000 claims description 4
- 238000004804 winding Methods 0.000 claims description 4
- 241000282412 Homo Species 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 229910001416 lithium ion Inorganic materials 0.000 claims description 2
- 229910052987 metal hydride Inorganic materials 0.000 claims description 2
- 229920006255 plastic film Polymers 0.000 claims description 2
- 239000002985 plastic film Substances 0.000 claims description 2
- 229920006254 polymer film Polymers 0.000 claims description 2
- 229910052720 vanadium Inorganic materials 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 229910005813 NiMH Inorganic materials 0.000 claims 1
- 229910052793 cadmium Inorganic materials 0.000 claims 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000000428 dust Substances 0.000 claims 1
- 238000002483 medication Methods 0.000 claims 1
- 229910052759 nickel Inorganic materials 0.000 claims 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 57
- 239000010410 layer Substances 0.000 description 23
- 239000000463 material Substances 0.000 description 11
- 239000011159 matrix material Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000010408 film Substances 0.000 description 7
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000011241 protective layer Substances 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920002367 Polyisobutene Polymers 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920005591 polysilicon Polymers 0.000 description 2
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016334 Feeling hot Diseases 0.000 description 1
- 239000004831 Hot glue Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000037058 blood plasma level Effects 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- OJIJEKBXJYRIBZ-UHFFFAOYSA-N cadmium nickel Chemical compound [Ni].[Cd] OJIJEKBXJYRIBZ-UHFFFAOYSA-N 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 239000002817 coal dust Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000004870 electrical engineering Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 238000005338 heat storage Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940126703 systemic medication Drugs 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/470,017 US20040219192A1 (en) | 2001-01-23 | 2002-01-14 | Devices and methods for heat-pulse assisted thermal applications of active subtances |
AT02703547T ATE297199T1 (de) | 2001-01-23 | 2002-01-14 | Vorrichtungen und verfahren zur hitzepuls- gestützten transdermalen applikation von wirkstoffen |
EP02703547A EP1353654B1 (de) | 2001-01-23 | 2002-01-14 | Vorrichtungen und verfahren zur hitzepuls-gestützten transdermalen applikation von wirkstoffen |
DE50203333T DE50203333D1 (de) | 2001-01-23 | 2002-01-14 | Vorrichtungen und verfahren zur hitzepuls-gestützten transdermalen applikation von wirkstoffen |
JP2002559012A JP3808439B2 (ja) | 2001-01-23 | 2002-01-14 | 作用物質のヒートパルス支援された経皮投与装置 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10102817A DE10102817B4 (de) | 2001-01-23 | 2001-01-23 | Vorrichtung und Verfahren zur Hitzepulsgestützten transdermalen Applikation von Wirkstoffen |
DE10102817.2 | 2001-01-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002058678A2 true WO2002058678A2 (de) | 2002-08-01 |
WO2002058678A3 WO2002058678A3 (de) | 2002-12-05 |
Family
ID=7671411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/000286 WO2002058678A2 (de) | 2001-01-23 | 2002-01-14 | Vorrichtungen und verfahren zur hitzepuls-gestützten transdermalen applikation von wirkstoffen |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040219192A1 (de) |
EP (1) | EP1353654B1 (de) |
JP (1) | JP3808439B2 (de) |
AT (1) | ATE297199T1 (de) |
DE (2) | DE10102817B4 (de) |
ES (1) | ES2243691T3 (de) |
WO (1) | WO2002058678A2 (de) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7070592B2 (en) | 1999-12-10 | 2006-07-04 | Massachusetts Institute Of Technology | Medical device with array of electrode-containing reservoirs |
US7892221B2 (en) | 1996-07-02 | 2011-02-22 | Massachusetts Institute Of Technology | Method of controlled drug delivery from implant device |
US7910151B2 (en) | 2002-08-16 | 2011-03-22 | Microchips, Inc. | Method for making device for controlled reservoir opening by electrothermal ablation |
US7985386B2 (en) | 2000-03-02 | 2011-07-26 | Microchips, Inc. | Implantable medical device for diagnostic sensing |
US8403915B2 (en) | 2004-09-01 | 2013-03-26 | Microchips, Inc. | Multi-opening reservoir devices for controlled release or exposure of reservoir contents |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10249853A1 (de) * | 2002-10-25 | 2004-05-13 | Liedtke, Rainer K., Dr. | Pflasterartige Chip-Systeme zur thermodynamischen Kontrolle topisch dermaler und transdermaler Systeme |
GB2414675B (en) * | 2004-06-05 | 2006-09-06 | Dewan Fazlul Hoque Chowdhury | Transdermal drug delivery device |
DE102004037823A1 (de) * | 2004-08-04 | 2006-03-16 | Viasys Healthcare Gmbh | Verdampfer, Beatmungsgerät sowie Verdampfungsverfahren |
EP1802258A4 (de) | 2004-09-13 | 2015-09-23 | Chrono Therapeutics Inc | Biosynchrone transdermale arzneiabgabe |
US10130801B1 (en) | 2005-02-07 | 2018-11-20 | Ipventure, Inc. | Electronic transdermal chemical delivery |
EP1901655B1 (de) * | 2005-07-13 | 2018-12-19 | Roche Diabetes Care GmbH | Lanzettenvorrichtung |
GB2467377A (en) * | 2009-02-02 | 2010-08-04 | Nemaura Pharma Ltd | Transdermal patch with extensor means actuated to expel drug towards the skin of a patient |
US9014799B2 (en) * | 2009-10-08 | 2015-04-21 | Palo Alto Research Center Incorporated | Transmucosal drug delivery device and method including electrically-actuated permeation enhancement |
US9017310B2 (en) * | 2009-10-08 | 2015-04-28 | Palo Alto Research Center Incorporated | Transmucosal drug delivery device and method including microneedles |
US8882748B2 (en) | 2009-10-08 | 2014-11-11 | Palo Alto Research Center Incorporated | Transmucosal drug delivery device and method including chemical permeation enhancers |
CZ22373U1 (cs) * | 2010-06-25 | 2011-06-20 | Royal Natural Medicine, S.R.O. | Vrstvená bandáž |
US9999720B2 (en) | 2012-09-27 | 2018-06-19 | Palo Alto Research Center Incorporated | Drug reconstitution and delivery device and methods |
US9005108B2 (en) | 2012-09-27 | 2015-04-14 | Palo Alto Research Center Incorporated | Multiple reservoir drug delivery device and methods |
US9744341B2 (en) | 2013-01-15 | 2017-08-29 | Palo Alto Research Center Incorporated | Devices and methods for intraluminal retention and drug delivery |
US9297083B2 (en) | 2013-12-16 | 2016-03-29 | Palo Alto Research Center Incorporated | Electrolytic gas generating devices, actuators, and methods |
US10278675B2 (en) | 2014-07-31 | 2019-05-07 | Palo Alto Research Center Incorporated | Implantable estrus detection devices, systems, and methods |
US9801660B2 (en) | 2014-07-31 | 2017-10-31 | Palo Alto Research Center Incorporated | Implantable fluid delivery devices, systems, and methods |
AU2016211330A1 (en) | 2015-01-28 | 2017-08-03 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
WO2018140743A1 (en) * | 2017-01-27 | 2018-08-02 | Northwestern University | Epidermal virtual reality devices |
EP3801732A4 (de) | 2018-05-29 | 2022-04-27 | Morningside Venture Investments Limited | Verfahren und systeme zur wirkstofffreisetzung |
WO2020102695A1 (en) * | 2018-11-16 | 2020-05-22 | Cti (Assignment For Benefit Of Creditors) Llc | Thermally regulated transdermal drug delivery system |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2931610A1 (de) * | 1979-08-03 | 1981-02-05 | Walter Landsrath | Heftpflaster |
US4398535A (en) * | 1979-11-27 | 1983-08-16 | Sunset Ltd. | Hyperthermia technique |
WO1985002124A1 (fr) * | 1983-11-10 | 1985-05-23 | Innovadata Ag | Procede et installation pour le degagement transdermique commande d'elements actifs, en particulier de medicaments |
WO2000018338A1 (en) * | 1998-09-29 | 2000-04-06 | Zars, Inc. | Methods and apparatus for improved administration of fentanyl and sufentanil |
WO2001064151A1 (en) * | 2000-02-29 | 2001-09-07 | Jie Zhang | Methods and apparatus for controlled heat to regulate transdermal delivery of medical substances |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5224928A (en) * | 1983-08-18 | 1993-07-06 | Drug Delivery Systems Inc. | Mounting system for transdermal drug applicator |
JPH01122037U (de) * | 1988-02-12 | 1989-08-18 | ||
DE3910543A1 (de) * | 1989-04-01 | 1990-10-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung |
DE4002281A1 (de) * | 1990-01-26 | 1991-08-01 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit dem wirkstoff tulobuterol |
DE4014913C2 (de) * | 1990-05-10 | 1996-05-15 | Lohmann Therapie Syst Lts | Miniaturisiertes transdermales therapeutisches System für die Iontophorese |
US5097828A (en) * | 1990-09-25 | 1992-03-24 | Richard Deutsch | Thermoelectric therapy device |
US5352456A (en) * | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
US5986163A (en) * | 1992-06-19 | 1999-11-16 | Augustine Medical, Inc. | Normothermic heater wound covering |
US5380272A (en) * | 1993-01-28 | 1995-01-10 | Scientific Innovations Ltd. | Transcutaneous drug delivery applicator |
RU2047298C1 (ru) * | 1993-05-27 | 1995-11-10 | Специализированное конструкторско-технологическое бюро "Норд" | Устройство для криомассажа |
DE4332093C2 (de) * | 1993-09-22 | 1995-07-13 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung |
US5885211A (en) * | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
US5947921A (en) * | 1995-12-18 | 1999-09-07 | Massachusetts Institute Of Technology | Chemical and physical enhancers and ultrasound for transdermal drug delivery |
DE19527925C2 (de) * | 1995-07-29 | 1997-07-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht |
US6527716B1 (en) * | 1997-12-30 | 2003-03-04 | Altea Technologies, Inc. | Microporation of tissue for delivery of bioactive agents |
DK1037686T3 (da) * | 1997-12-11 | 2006-01-02 | Alza Corp | Apparat til forögelse af transdermal gennemströmning af midler |
US6022316A (en) * | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
US6692456B1 (en) * | 1999-06-08 | 2004-02-17 | Altea Therapeutics Corporation | Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor |
US20020156415A1 (en) * | 2000-08-24 | 2002-10-24 | Redding Bruce K. | Ultrasonically enhanced substance delivery system and device |
DE10103860B4 (de) * | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
AU2003265226A1 (en) * | 2002-03-11 | 2003-12-19 | Altea Therapeutics Corporation | Transdermal drug delivery device, method and use |
DE10249853A1 (de) * | 2002-10-25 | 2004-05-13 | Liedtke, Rainer K., Dr. | Pflasterartige Chip-Systeme zur thermodynamischen Kontrolle topisch dermaler und transdermaler Systeme |
-
2001
- 2001-01-23 DE DE10102817A patent/DE10102817B4/de not_active Expired - Lifetime
-
2002
- 2002-01-14 ES ES02703547T patent/ES2243691T3/es not_active Expired - Lifetime
- 2002-01-14 DE DE50203333T patent/DE50203333D1/de not_active Expired - Lifetime
- 2002-01-14 WO PCT/EP2002/000286 patent/WO2002058678A2/de active IP Right Grant
- 2002-01-14 JP JP2002559012A patent/JP3808439B2/ja not_active Expired - Fee Related
- 2002-01-14 EP EP02703547A patent/EP1353654B1/de not_active Expired - Lifetime
- 2002-01-14 AT AT02703547T patent/ATE297199T1/de not_active IP Right Cessation
- 2002-01-14 US US10/470,017 patent/US20040219192A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2931610A1 (de) * | 1979-08-03 | 1981-02-05 | Walter Landsrath | Heftpflaster |
US4398535A (en) * | 1979-11-27 | 1983-08-16 | Sunset Ltd. | Hyperthermia technique |
WO1985002124A1 (fr) * | 1983-11-10 | 1985-05-23 | Innovadata Ag | Procede et installation pour le degagement transdermique commande d'elements actifs, en particulier de medicaments |
WO2000018338A1 (en) * | 1998-09-29 | 2000-04-06 | Zars, Inc. | Methods and apparatus for improved administration of fentanyl and sufentanil |
WO2001064151A1 (en) * | 2000-02-29 | 2001-09-07 | Jie Zhang | Methods and apparatus for controlled heat to regulate transdermal delivery of medical substances |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7892221B2 (en) | 1996-07-02 | 2011-02-22 | Massachusetts Institute Of Technology | Method of controlled drug delivery from implant device |
US7901397B2 (en) | 1996-07-02 | 2011-03-08 | Massachusetts Institute Of Technology | Method for operating microchip reservoir device |
US7070592B2 (en) | 1999-12-10 | 2006-07-04 | Massachusetts Institute Of Technology | Medical device with array of electrode-containing reservoirs |
US7985386B2 (en) | 2000-03-02 | 2011-07-26 | Microchips, Inc. | Implantable medical device for diagnostic sensing |
US7910151B2 (en) | 2002-08-16 | 2011-03-22 | Microchips, Inc. | Method for making device for controlled reservoir opening by electrothermal ablation |
US8211092B2 (en) | 2002-08-16 | 2012-07-03 | Microchips, Inc. | Containment device with multi-layer reservoir cap structure |
US8403915B2 (en) | 2004-09-01 | 2013-03-26 | Microchips, Inc. | Multi-opening reservoir devices for controlled release or exposure of reservoir contents |
Also Published As
Publication number | Publication date |
---|---|
ATE297199T1 (de) | 2005-06-15 |
DE50203333D1 (de) | 2005-07-14 |
JP3808439B2 (ja) | 2006-08-09 |
WO2002058678A3 (de) | 2002-12-05 |
DE10102817A1 (de) | 2002-08-01 |
US20040219192A1 (en) | 2004-11-04 |
EP1353654B1 (de) | 2005-06-08 |
DE10102817B4 (de) | 2006-01-12 |
JP2004525674A (ja) | 2004-08-26 |
EP1353654A2 (de) | 2003-10-22 |
ES2243691T3 (es) | 2005-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1353654B1 (de) | Vorrichtungen und verfahren zur hitzepuls-gestützten transdermalen applikation von wirkstoffen | |
DE60036306T2 (de) | System zur verabreichung von medikamenten mit veränderbarer rate | |
EP0387694B1 (de) | Pflaster als therapeutisches System zur Verabreichung von Wirkstoffen an die Haut mit einer abgestuften Wirkstoffabgabe, Verfahren zu seiner Herstellung sowie Verwendung | |
DE4014913C2 (de) | Miniaturisiertes transdermales therapeutisches System für die Iontophorese | |
DE69930401T2 (de) | Vorrichtung zur abgabe von fentanyl und sufentanil | |
EP0356382B1 (de) | Mehrschichtiges Pflaster | |
DE3905050C2 (de) | ||
DE602005004782T2 (de) | Transdermale arzneimittelabgabevorrichtung durch dehnung/lockerung | |
EP1418951B1 (de) | Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl | |
EP0341202A1 (de) | Transdermale Monolithsysteme | |
WO1988001516A1 (en) | Transdermal therapeutic system, its use and production process | |
DE3225748A1 (de) | Ionophorese-vorrichtung | |
CH690751A5 (de) | Vorrichtung zur transdermalen Elektrotransport-Abgabe von Fentanyl und Sufentanil. | |
DE19681421B4 (de) | Vorrichtung und Bereitstellungsverfahren für eine transdermale Elektrotransport-Abgabe von Fentanyl und Sufentanil | |
WO2011107525A2 (de) | Aktivierbares arzneimittelabgabesystem | |
DE19945814A1 (de) | Verfahren zur Zubereitung eines pharmazeutischen Artemisia-Extraktes und Vorrichtung zur elektrischen Moxibustion unter Verwendung des Extraktes | |
CH662740A5 (de) | Einrichtung zur gesteuerten transdermalen zufuehrung von pharmazeutischen wirkstoffen. | |
EP3280371B1 (de) | Elektrisch erwärmbares pflaster | |
DE3319469C2 (de) | ||
EP0742716B1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
WO2001026636A1 (de) | Superfizielles therapeutisches system zur topischen applikation von acetylsalicylsäure zur behandlung von akne-erkrankungen | |
Deshpande et al. | Iontophoresis: A physical approach to transdermal drug delivery system | |
EP4009947A1 (de) | Lagtime-verkürzung/eisspray | |
DE4217039C2 (de) | Vorrichtung für die iontophoretische Applikation, bei der der Wirkstofffluß maximiert ist, Vorrichtung zur Bestimmung der zugehörigen Frequenz sowie entsprechendes Iontophoreseverfahren | |
EP1726302A2 (de) | Für die Wärmeanwendung zur Beschleunigung der Permeation von Wirkstoffen geeignetes transdermales therapeutisches System und seine Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002703547 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002559012 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10470017 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2002703547 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002703547 Country of ref document: EP |